![Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence | Signal Transduction and Targeted Therapy Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-021-00729-7/MediaObjects/41392_2021_729_Fig1_HTML.png)
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence | Signal Transduction and Targeted Therapy
![Frontiers | The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand? Frontiers | The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?](https://www.frontiersin.org/files/Articles/574271/fimmu-11-574271-HTML-r2/image_m/fimmu-11-574271-g001.jpg)
Frontiers | The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
![Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges: Molecular Therapy - Oncolytics Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/cb8f8e60-9a4d-44df-a8df-f8cde148c9df/fx1_lrg.jpg)
Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges: Molecular Therapy - Oncolytics
![CD16/PD-L1 bi-specific aptamer for cancer immunotherapy through recruiting NK cells and acting as immunocheckpoint blockade: Molecular Therapy - Nucleic Acids CD16/PD-L1 bi-specific aptamer for cancer immunotherapy through recruiting NK cells and acting as immunocheckpoint blockade: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/44b8c0ac-0b8b-4621-adbe-85f6e4b1ea88/fx1_lrg.jpg)
CD16/PD-L1 bi-specific aptamer for cancer immunotherapy through recruiting NK cells and acting as immunocheckpoint blockade: Molecular Therapy - Nucleic Acids
![Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy | Nature Reviews Cancer Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy | Nature Reviews Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrc.2016.36/MediaObjects/41568_2016_Article_BFnrc201636_Fig1_HTML.jpg)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy | Nature Reviews Cancer
![Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies | Nature Reviews Endocrinology Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies | Nature Reviews Endocrinology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrendo.2016.205/MediaObjects/41574_2017_Article_BFnrendo2016205_Fig1_HTML.jpg)